Shearman & Sterling represented GMS Ventures and Investments in the transaction. Outlook Therapeutics, Inc. (Nasdaq: OTLK), a biopharmaceutical company working to achieve the first approval for an...
Shearman & Sterling represented GMS Ventures and Investments in the transaction. Outlook Therapeutics, Inc. (Nasdaq: OTLK), a biopharmaceutical company working to achieve the first approval for an...
You must be a Standard 1 Year member to access this content.